These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19788765)

  • 1. A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".
    Wassenaar DR; Ramjee G
    BMC Med Ethics; 2009 Sep; 10():16. PubMed ID: 19788765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?
    Lavery JV; Singer PA; Ridzon R; Singh JA; Slutsky AS; Anisko JJ; Buchanan D
    PLoS Med; 2009 Jun; 6(6):e1000071. PubMed ID: 19513106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.
    Tucker T; Slack C
    Lancet; 2003 Sep; 362(9388):995. PubMed ID: 14513854
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS research. Drug trials without the drugs?
    Cohen J
    Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicides. Raising new barriers against HIV infection.
    Trager RS
    Science; 2003 Jan; 299(5603):39. PubMed ID: 12511630
    [No Abstract]   [Full Text] [Related]  

  • 7. A second chance for microbicides.
    Baleta A
    Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials in developing countries: scientific and ethical issues.
    Studdert DM; Brennan TA
    Med J Aust; 1998 Nov; 169(10):545-8. PubMed ID: 9861913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global drug gap: policy implications for microbicides.
    Reich MR
    AIDS; 2001 Feb; 15 Suppl 1():S14-7. PubMed ID: 11403006
    [No Abstract]   [Full Text] [Related]  

  • 10. Using mathematical modeling to bridge phase 3 microbicide trials with public health decision making.
    Mâsse BR; Boily MC; Desai K
    J Acquir Immune Defic Syndr; 2009 Apr; 50(4):434-5. PubMed ID: 19322040
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing perinatal HIV transmission--does the end justify the means?
    Moodley K
    S Afr Med J; 1998 Jul; 88(7):808, 810. PubMed ID: 9698705
    [No Abstract]   [Full Text] [Related]  

  • 12. Content analysis of local newspaper coverage of the microbicide trials in South Africa.
    Cooper S; Anafi P; Sun C; Naidoo N; Reddy P; Buchanan D
    Int Q Community Health Educ; 2008-2009; 29(2):105-21. PubMed ID: 19546087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment and research in resource-poor countries.
    Hirschel B
    Lancet; 2003 Feb; 361(9355):434-5. PubMed ID: 12573412
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbicide trials update. Newspaper Article.
    von Bubnoff A; Kresge KJ; Morris A
    IAVI Rep; 2008; 12(2):16. PubMed ID: 20213865
    [No Abstract]   [Full Text] [Related]  

  • 15. Called to account.
    Aldhous P
    Nature; 2004 Jul; 430(6996):133. PubMed ID: 15241382
    [No Abstract]   [Full Text] [Related]  

  • 16. Provision of treatment in HIV-1 vaccine trials in developing countries.
    Fitzgerald DW; Pape JW; Wasserheit JN; Counts GW; Counts GW; Corey L
    Lancet; 2003 Sep; 362(9388):993-4. PubMed ID: 14513852
    [No Abstract]   [Full Text] [Related]  

  • 17. Some design issues in trials of microbicides for the prevention of HIV infection.
    Fleming TR; Richardson BA
    J Infect Dis; 2004 Aug; 190(4):666-74. PubMed ID: 15272392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides & their implications in HIV prevention.
    Abdool Karim SS; Baxter C
    Indian J Med Res; 2010 Dec; 132(6):656-9. PubMed ID: 21245610
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-1 care in resource-poor settings: a view from Haiti.
    Mukherjee JS
    Lancet; 2003 Sep; 362(9388):994-5. PubMed ID: 14513853
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010).
    Liniker E; Harrison M; Weaver JM; Agrawal N; Chhabra A; Kingshott V; Bailey S; Eisen TG; Corrie PG
    Br J Cancer; 2013 Oct; 109(8):2051-7. PubMed ID: 24064969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.